Martha Werler | Profiles RNS

Martha Werler, DSc

Professor

Boston University School of Public Health

Dept of Epidemiology

MPH, University of Michigan at Ann Arbor
DSc, Boston University

Websites

	School of Public Health Faculty
	Slone Epidemiology Center Faculty
	ResearchGate
	Google Scholar
	LinkedIn

ORCID : 0000-0003-3392-6814

Dr. Werler is Professor and Chair of Epidemiology. She is a perinatal epidemiologist whose NIH- and CDC- supported research includes projects on maternal serum markers of infection and abdominal wall defects; gene-environment interactions and clubfoot; medications, folic acid intake, and inheritance in relation to spina bifida; and psycho-social and cognitive outcomes in children born with craniofacial birth defects. She has published over 175 papers and book chapters; received the National Birth Defect Prevention Network Oakley Award, the Society for Pediatric and Perinatal Epidemiologic Research Mentoring Award, and the Teratology Society Fraser Award; and served on numerous NIH advisory and review boards. Dr. Werler is Director of the BU Reproductive, Perinatal, and Pediatric Epidemiology training program for pre-doctoral candidates in Epidemiology and teaches Design and Conduct of Case-Control Studies.

Chair of Epidemiology
Boston University School of Public Health
Epidemiology

2014 National Birth Defects Prevention Network: Godfrey P. Oakley Award

2012 Soc. Pediatric & Perinatal Epidemiology Research: Mentoring Award

2003 BU School of Public Health: Distinguished Alumni

2000 Teratology Society: Clark Fraser New Investigator Award

BU Research
NIH RePORTER Research

Pregnancy in women with congenital physical disabilities: Risk factors, birth outcomes, and mediation
04/01/2019 - 03/31/2021 (PI)
NIH/National Institute of Child Health & Human Development
1R03HD098507-01

A Population-Based Study to Quantify the Risks of Opioid Analgesics in Pregnancy
09/12/2019 - 08/31/2020 (Subcontract PI)
Queen's University at Kingston NIH NICHD
1R03HD099617-01

Massachusetts Center for Birth Defects Research and Prevention (BD STEPS) - Core
02/28/2019 - 06/30/2020 (Subcontract PI)
Comm. of Mass./Department of Public Health HHS CDC
6U01DD001224-01M002

Safety, pharmacokinetics and efficacy of extended-release naltrexone in pregnant women with opioid use disorder
10/01/2018 - 05/31/2020 (Subcontract PI)
Boston Medical Center Corporation NIH NICHD
1R01HD096798-01

Exploring Modifiable Factors for Folic Acid Resistant Spina Bifida
09/01/2015 - 04/30/2019 (PI)
HHS/CDC/National Center for Birth Defects and Developmental Disabilities
6 U01DD001184-03-02

Society for Pediatric and Perinatal Epidemiologic Research
04/01/2014 - 03/31/2019 (PI)
NIH/National Institute of Child Health & Human Development
5R13HD055094-12

Zika Virus Colombia Cohort Study
09/01/2017 - 05/31/2018 (Subcontract PI)
Vysnova Partners Inc., HHS CDC

BURPPE: BU Reproductive, Perinatal, and Pediatric Epidemiology Training Program
05/01/2016 - 08/31/2017 (PI)
NIH/National Institute of Child Health & Human Development
4T32HD052458-10

Hemifacial Microsomia: Psychosocial and Other Sequelae
07/02/2010 - 06/30/2017 (PI)
NIH/National Institute of Dental & Craniofacial Research
3R01DE011939-16S1

Comparative Safety of Buprenorphine vs. Methadone in Pregnancy
09/30/2014 - 04/30/2017 (Subcontract PI)
Queen's University at Kingston NIH NICHD
1R21JD081271-01

Showing 10 of 15 results. Show All Results

Title

Yr	Title	Project-Sub Proj	Pubs
2020	Pregnancy in women with congenital physical disabilities: Risk factors, birth outcomes, and mediation	5R03HD098507-02
2020	Pregnancy in women with congenital physical disabilities: Risk factors, birth outcomes, and mediation	5R03HD098507-02
2019	Pregnancy in women with congenital physical disabilities: Risk factors, birth outcomes, and mediation	1R03HD098507-01
2018	BD-STEPS II (Birth Defects Study To Evaluate Pregnancy exposureS) - Core	1U01DD001224-01	5
2018	BD-STEPS II (Birth Defects Study To Evaluate Pregnancy exposureS) - Core	6U01DD001224-01M002	5
2018	EXPLORING MODIFIABLE FACTORS FOR FOLIC ACID RESISTANT SPINA BIFIDA	6U01DD001184-03M001	6
2018	EXPLORING MODIFIABLE FACTORS FOR FOLIC ACID RESISTANT SPINA BIFIDA	6U01DD001184-03M002	6
2018	Society for Pediatric and Perinatal Epidemiologic Research	5R13HD055094-12	2
2017	EXPLORING MODIFIABLE FACTORS FOR FOLIC ACID RESISTANT SPINA BIFIDA	5U01DD001184-03	6
2017	Society for Pediatric and Perinatal Epidemiologic Research	5R13HD055094-11	2

Showing 10 of 55 results. Show All Results

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis Copy PMIDs To Clipboard

Kerr SM, Parker SE, Mitchell AA, Tinker SC, Werler MM. Folic acid antagonist use before and during pregnancy and risk for selected birth defects. Birth Defects Res. 2020 Sep 02.View Related Profiles.

Mitchell, Allen
Werler, Martha
Parker, Samantha

PMID: 32875745

Hansen C, Desrosiers TA, Wisniewski K, Strickland MJ, Werler MM, Gilboa SM. Use of antihistamine medications during early pregnancy and selected birth defects: The National Birth Defects Prevention Study, 1997-2011. Birth Defects Res. 2020 Jul 13. PMID: 32657014

Schrager NL, Adrien N, Werler MM, Parker SE, Van Bennekom C, Mitchell AA. Trends in first-trimester nausea and vomiting of pregnancy and use of select treatments: Findings from the National Birth Defects Prevention Study. Paediatr Perinat Epidemiol. 2020 Jul 04.View Related Profiles.

Mitchell, Allen
Werler, Martha
Parker, Samantha

PMID: 32623767

Lau B, Duggal P, Ehrhardt S, Armenian H, Branas CC, Colditz GA, Fox MP, Hawes SE, He J, Hofman A, Keyes K, Ko AI, Lash TL, Levy D, Lu M, Morabia A, Ness R, Nieto FJ, Schisterman EF, Stürmer T, Szklo M, Werler M, Wilcox AJ, Celentano DD. Perspectives on the Future of Epidemiology: A Framework for Training. Am J Epidemiol. 2020 Jul 01; 189(7):634-639.View Related Profiles.

Werler, Martha
Fox, Matthew

PMID: 32003778

Adrien N, Petersen JM, Parker SE, Werler MM. Vasoactive exposures and risk of amniotic band syndrome and terminal transverse limb deficiencies. Birth Defects Res. 2020 Aug; 112(14):1074-1084.View Related Profiles.

Werler, Martha
Parker, Samantha

PMID: 32573119

Kaelin VC, Wallace ER, Werler MM, Collett BR, Khetani MA. Community participation in youth with craniofacial microsomia. Disabil Rehabil. 2020 Jun 01; 1-8.View Related Profiles.

Werler, Martha
Khetani, Mary

PMID: 32478589

Petersen JM, Esposito DB, Werler MM. Selective serotonin reuptake inhibitor use patterns among commercially insured US pregnancies (2005-2014). Arch Womens Ment Health. 2020 Mar 28. PMID: 32222834

Parker SE, Werler MM. Prenatal exposure to acetaminophen and neurodevelopment. Paediatr Perinat Epidemiol. 2020 05; 34(3):225-226.View Related Profiles.

Werler, Martha
Parker, Samantha

PMID: 32201959

Parker SE, Collett BR, Werler MM. Maternal acetaminophen use during pregnancy and childhood behavioural problems: Discrepancies between mother- and teacher-reported outcomes. Paediatr Perinat Epidemiol. 2020 05; 34(3):299-308.View Related Profiles.

Werler, Martha
Parker, Samantha

PMID: 31693212

Collett BR, Chapman K, Wallace ER, Kinter SL, Heike CL, Speltz ML, Werler M. Speech, Language, and Communication Skills of Adolescents With Craniofacial Microsomia. Am J Speech Lang Pathol. 2019 11 19; 28(4):1571-1581. PMID: 31580699

Showing 10 of 223 results. Show More

Darling AM, Werler MM, Cantonwine DE, Fawzi WW, McElrath TF. Timing and Amount of Gestational Weight Gain in Association with Adverse Birth Outcomes. Epidemiology. 2019 09; 30(5):695-705. PMID: 31205288

Petersen JM, Parker SE, Benedum CM, Mitchell AA, Tinker SC, Werler MM. Periconceptional folic acid and risk for neural tube defects among higher risk pregnancies. Birth Defects Res. 2019 11 15; 111(19):1501-1512.View Related Profiles.

Mitchell, Allen
Werler, Martha
Parker, Samantha

PMID: 31433116

Wachman EM, Saia K, Miller M, Valle E, Shrestha H, Carter G, Werler M, Jones H. Naltrexone Treatment for Pregnant Women With Opioid Use Disorder Compared With Matched Buprenorphine Control Subjects. Clin Ther. 2019 09; 41(9):1681-1689.View Related Profiles.

Wachman, Elisha
Saia, Kelley
Werler, Martha

PMID: 31358302

Petersen JM, Parker SE, Crider KS, Tinker SC, Mitchell AA, Werler MM. One-Carbon Cofactor Intake and Risk of Neural Tube Defects Among Women Who Meet Folic Acid Recommendations: A Multicenter Case-Control Study. Am J Epidemiol. 2019 06 01; 188(6):1136-1143.View Related Profiles.

Mitchell, Allen
Werler, Martha
Parker, Samantha

PMID: 30976786

Darling AM, Werler MM, Cantonwine DE, Fawzi WW, McElrath TF. Accuracy of a mixed effects model interpolation technique for the estimation of pregnancy weight values. J Epidemiol Community Health. 2019 08; 73(8):786-792. PMID: 31152073

Werler MM, Stuver SO, Healey MA, LaMorte WW. The Future of Teaching Epidemiology. Am J Epidemiol. 2019 05 01; 188(5):825-829.View Related Profiles.

Werler, Martha
Healey, Megan
Stuver, Sherri
LaMorte, Wayne

PMID: 30865216

Ryan MA, Olshan AF, Canfield MA, Hoyt AT, Scheuerle AE, Carmichael SL, Shaw GM, Werler MM, Fisher SC, Desrosiers TA. Sociodemographic, health behavioral, and clinical risk factors for anotia/microtia in a population-based case-control study. Int J Pediatr Otorhinolaryngol. 2019 Jul; 122:18-26. PMID: 30928866

Tinker SC, Reefhuis J, Bitsko RH, Gilboa SM, Mitchell AA, Tran EL, Werler MM, Broussard CS. Use of benzodiazepine medications during pregnancy and potential risk for birth defects, National Birth Defects Prevention Study, 1997-2011. Birth Defects Res. 2019 06 01; 111(10):613-620.View Related Profiles.

Year	Publications
1985	1
1986	2
1987	3
1988	1
1989	3
1990	3
1991	1
1992	3
1993	3
1994	2
1995	2
1996	3
1997	2
1999	4
2000	4
2001	3
2002	5
2003	6
2004	3
2005	5
2006	6
2007	7
2008	8
2009	13
2010	7
2011	18
2012	12
2013	16
2014	15
2015	12
2016	12
2017	7
2018	9
2019	12
2020	8